Arrivent Biopharma, Inc. · NASDAQ:AVBP

ORBIMED ADVISORS LLC reported a 5.80% stake in Arrivent Biopharma, Inc. (Schedule 13D/A)

Event Oct 6, 2026 · Filed Oct 8, 2026

ORBIMED ADVISORS LLC reported a 5.80% stake in Arrivent Biopharma, Inc., 2,875,962 shares, with active intent on Oct 6, 2026. Filed Oct 8, 2026 (Schedule 13D/A).

Stake
5.80%
Shares
2,875,962
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC5.80%2,875,962
OrbiMed Capital GP VIII LLC2.90%1,437,981
OrbiMed Asia GP IV, L.P.2.90%1,437,981
OrbiMed Advisors IV Limited2.90%1,437,981

Source

View original at SEC

Related